Fusion Pharmaceuticals
Alex Nielsen, PhD, is a highly skilled radiochemist currently serving as Radiochemist III at Fusion Pharmaceuticals since September 2021, following a role as Radiochemist II. Prior experience includes a position as Postdoctoral Research Scientist at University Health Network from August 2020 to September 2021 and extensive research experience at McMaster University spanning from 2012 to August 2020, where roles included Postdoctoral Research Fellow, PhD Candidate, Research Technician, and Teaching Assistant in scientific literacy. Earlier internships at AstraZeneca R&D focused on synthesizing biologically active compounds in oncology. Alex Nielsen holds a PhD in Chemical Biology from McMaster University and a Teaching and Learning Scholar Certificate, along with a B.Sc. (Hons) in Integrated Science with a concentration in Biochemistry.
This person is not in any teams
This person is not in any offices